We offer contract manufacturing services of cell processing products to medical institutions providing regenerative medicine in daily practice or clinical study, since our CPF (cell processing facility) is authorized by the Japanese Government to manufacture cell processing products.
We offer custom-made cardiomyocytes, endothelial cells, mural cells and mesenchymal stem cells from iPS cells or ES cells provided by clients.
We offer a contract building-up service of MCB or WCB by expanding a stem cells with self-renewal capacity such as iPS cells and ES cells.
We offer a contract drug screening service with iPSC provided from a customer.